12.05.2019 AAKASHAYA PATRA EXCLUSIVE STOCK FOR INVESTMENT: Jagsonpal Pharma (CMP Rs. 26.6) Target - 52- 55, SL - 18 Time Frame 18 to 60 Months Incorporated in 1964, Delhi based Jagsonpal Pharmaceuticals Limited develops and manufactures active pharmaceutical ingredients (APIs) and formulations. Its APIs include allylestrenol, dextropropoxyphene HCL, dextropropoxyphene napsylate, disulfiram, thiopental sodium, thiopental acid, tolnaftate, and sildenafil citrate, as well as metformin HCL, BP, USP, and EP. The company also offers formulations for various therapeutic categories, such as anabolic steroids, analgesics, anesthetics, anti-allergic, anti-asthamatics, anticholinergic agents, anti-convulsants, anti-diabetics, anti-diarrhoeals, antiemetics,anti-epileptics, anti-fungal agents, anti-gout agents, anti-inflammatory agents, anti-malarials, anti-nauseants, anti-protozoals, anti-pyretic, antirheumatic drugs, anti-spasmodic agents, and anti-septic agents. The co...
Comments
Post a Comment